COPD cachexia: deciphering the impact of antioxidants, iron and mitochondrial function using 'omics approaches
慢性阻塞性肺病恶病质:使用“组学方法”解读抗氧化剂、铁和线粒体功能的影响
基本信息
- 批准号:10209552
- 负责人:
- 金额:$ 66.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-10 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AminolevulinateAntioxidantsBindingBiological AssayBiopsyBody Weight decreasedBronchoalveolar LavageCachexiaCancer PatientCardiovascular systemCause of DeathChronic Obstructive Airway DiseaseCitrate (si)-SynthaseCytochromesDataDefectElectron TransportEnzymesEquilibriumEtiologyFerritinFramingham Heart StudyGenesGeneticGenetic TranscriptionGenetic TranslationGenetic VariationHealthcareHeartHemeHomeostasisImpairmentIntakeInvestigationIronIron Regulatory Protein 2Jackson Heart StudyLifeLungMalignant NeoplasmsMediatingMediationMedicineMessenger RNAMitochondriaMulti-Ethnic Study of AtherosclerosisMuscleMuscular AtrophyMyoblastsNational Heart, Lung, and Blood InstituteOxidative StressParticulate MatterPathway interactionsPatientsPhenotypePlasmaPopulationPrevalenceProductionProteinsQuantitative Trait LociReactive Oxygen SpeciesRegulationResearchResponse ElementsRiskRisk FactorsRoleSerumSeveritiesSeverity of illnessSkeletal MuscleSmokeSmokerSmokingSystemTestingThinnessTocopherolsToxic effectTrans-Omics for Precision MedicineTranscriptTranslationsUnited StatesVariantVitamin EVitaminsWorkabsorptionalpha-tocopherol transfer proteincancer cachexiacigarette smokecohortcomorbiditygenetic variantgenome wide association studygenomic variationheme biosynthesismitochondrial dysfunctionmortalitymuscle formpatient populationpreservationpublic health relevancerecruittherapeutic developmenttherapeutic targettranscriptome sequencingtranscriptomicswhole genome
项目摘要
SUMMARY
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death in the United States
with mortality continuing to rise despite advances in medicine. Cachexia, a form of muscle wasting, is a
debilitating co-morbidity whose prevalence increases with severity of COPD. But, cachexia still occurs among
COPD patients with milder disease severity. Cachexia is most often thought of with respect to cancer. However,
by population prevalence there are more COPD patients with cachexia than cancer patients with cachexia. Yet
there have been few studies investigating the etiology of COPD cachexia underscoring the need for
investigations of COPD cachexia and weight-loss. Accumulating data including our own points to a role for iron
toxicity in the etiology of COPD cachexia. Heme is an essential component of mitochondrial cytochromes
providing protection from reactive oxygen species (ROS). Defects in heme biosynthesis cause buildup of free
iron, ROS and mitochondrial dysfunction. Buildup of free iron leads to iron toxicity and production of ROS
particularly in the absence of adequate intake of antioxidants such as Vitamins E. As such, our overarching
hypothesis is iron toxicity in COPD cachexia is driven by impaired antioxidant and mitochondrial function. This
study has three specific aims: 1) To determine whether genomic variation associated with the absorption and
regulation of Vitamin E is more common in COPD cachexia; 2) To assess whether plasma Vitamin E in subjects
with COPD cachexia are associated with impaired mitochondrial function; Exploratory Aim) To test whether
iron induced transcriptional dysregulation signatures in myoblasts are preserved in transcriptomics signatures
associated with COPD cachexia in skeletal muscle biopsies. Elucidating mechanisms of mitochondrial
dysfunction in COPD cachexia has the potential to aid the development of therapeutics targeting mitochondrial
oxidative stress. As future research, we plan to test whether ‘omic regions and metabolites identified as
associated with COPD cachexia directly effect pathways involved with Vitamin E and mitochondrial function
using targeted assays in myoblasts or other appropriate systems.
摘要
慢性阻塞性肺疾病(COPD)是美国第四大死因
尽管医学取得了进步,但死亡率仍在继续上升。恶病质是肌肉萎缩的一种形式,是一种
衰弱的共病,其患病率随着COPD的严重程度而增加。但是,恶病质仍在
疾病严重程度较轻的COPD患者。恶病质最常被认为是与癌症有关的。然而,
从人群患病率来看,COPD患者合并恶病质的人数多于癌症患者合并恶病质的人数。还没有
很少有研究探讨COPD恶病质的病因,强调有必要
慢性阻塞性肺疾病恶病质与减肥的调查。积累数据,包括我们自己对铁的作用
慢性阻塞性肺疾病恶病质病因学的毒性。血红素是线粒体细胞色素的重要组成部分
提供对活性氧物种(ROS)的保护。血红素生物合成缺陷导致游离
铁、ROS和线粒体功能障碍。游离铁的积聚导致铁中毒和ROS的产生
尤其是在缺乏维生素E等抗氧化剂的情况下,我们最主要的
假说认为COPD恶病质中铁毒性是由抗氧化剂和线粒体功能受损引起的。这
这项研究有三个具体目标:1)确定基因组变异是否与吸收和
维生素E的调节在COPD恶病质中更常见;2)评估受试者血浆维生素E
患有COPD的恶病质与线粒体功能受损有关;探索性目的)测试
成肌细胞中铁诱导的转录失调信号保存在转录信号中
与骨骼肌活检中的慢性阻塞性肺疾病恶病质有关。阐明线粒体的作用机制
COPD恶病质的功能障碍有可能帮助开发针对线粒体的治疗方法
氧化应激。作为未来的研究,我们计划测试被鉴定为
与COPD相关的恶病质直接影响与维生素E和线粒体功能有关的通路
在成肌细胞或其他适当的系统中使用靶向分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Merry-Lynn Noelle McDonald Donnelly其他文献
Merry-Lynn Noelle McDonald Donnelly的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Merry-Lynn Noelle McDonald Donnelly', 18)}}的其他基金
COPD cachexia: deciphering the impact of antioxidants, iron and mitochondrial function using 'omics approaches
慢性阻塞性肺病恶病质:使用“组学方法”解读抗氧化剂、铁和线粒体功能的影响
- 批准号:
10677563 - 财政年份:2021
- 资助金额:
$ 66.65万 - 项目类别:
COPD Cachexia: Deciphering the Impact of Antioxidants, Iron and Mitochondrial Function Using 'Omics Approaches
慢性阻塞性肺病恶病质:使用“组学方法”解读抗氧化剂、铁和线粒体功能的影响
- 批准号:
10659943 - 财政年份:2021
- 资助金额:
$ 66.65万 - 项目类别:
COPD cachexia: deciphering the impact of antioxidants, iron and mitochondrial function using 'omics approaches
慢性阻塞性肺病恶病质:使用“组学方法”解读抗氧化剂、铁和线粒体功能的影响
- 批准号:
10426201 - 财政年份:2021
- 资助金额:
$ 66.65万 - 项目类别:
Network Medicine Approaches to Cachexia in COPD
网络医学治疗慢性阻塞性肺病恶病质的方法
- 批准号:
9376992 - 财政年份:2017
- 资助金额:
$ 66.65万 - 项目类别:
Network Medicine Approaches to Cachexia in COPD
网络医学治疗慢性阻塞性肺病恶病质的方法
- 批准号:
9418079 - 财政年份:2017
- 资助金额:
$ 66.65万 - 项目类别:
Network Medicine Approaches to Cachexia in COPD
网络医学治疗慢性阻塞性肺病恶病质的方法
- 批准号:
8821047 - 财政年份:2015
- 资助金额:
$ 66.65万 - 项目类别:
Network Medicine Approaches to Cachexia in COPD
网络医学治疗慢性阻塞性肺病恶病质的方法
- 批准号:
9105437 - 财政年份:2015
- 资助金额:
$ 66.65万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 66.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 66.65万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 66.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 66.65万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 66.65万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 66.65万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 66.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 66.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 66.65万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 66.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




